Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children

Endothelial dysfunction (ED) and oxidative stress are potential new pathomechanisms of cardiovascular diseases in patients with chronic kidney disease (CKD). The aim of the study was to assess the association between endothelial dysfunction, oxidative stress biomarkers, and cardiovascular risk facto...

Full description

Bibliographic Details
Main Authors: Dorota Drożdż, Monika Łątka, Tomasz Drożdż, Krystyna Sztefko, Przemko Kwinta
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Oxidative Medicine and Cellular Longevity
Online Access:http://dx.doi.org/10.1155/2018/1619293
id doaj-482d1924de1a471aafb595480d6a7e11
record_format Article
spelling doaj-482d1924de1a471aafb595480d6a7e112020-11-24T21:52:46ZengHindawi LimitedOxidative Medicine and Cellular Longevity1942-09001942-09942018-01-01201810.1155/2018/16192931619293Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in ChildrenDorota Drożdż0Monika Łątka1Tomasz Drożdż2Krystyna Sztefko3Przemko Kwinta4Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, 265 Wielicka St., 30-663 Krakow, PolandDepartment of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, 265 Wielicka St., 30-663 Krakow, Poland1st Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, 17 Kopernika St., 31-501 Krakow, PolandDepartment of Clinical Biochemistry, Jagiellonian University Medical College, 265 Wielicka St., 30-663 Krakow, PolandDepartment of Pediatrics, Jagiellonian University Medical College, 265 Wielicka St., 30-663 Krakow, PolandEndothelial dysfunction (ED) and oxidative stress are potential new pathomechanisms of cardiovascular diseases in patients with chronic kidney disease (CKD). The aim of the study was to assess the association between endothelial dysfunction, oxidative stress biomarkers, and cardiovascular risk factors in children with CKD. Serum oxidized LDL (oxLDL), protein carbonyl group, urea, creatinine, cystatin C, thrombomodulin, asymmetric dimethylarginine (ADMA), von Willebrand factor, brain natriuretic peptide (BNP), lipids, high sensitivity C-reactive protein, intercellular adhesion molecule-1 levels, and albuminuria were measured. Anthropometric, ambulatory blood pressure (BP) measurements and echocardiography were performed. The studied group consisted of 59 patients aged 0.7–18.6 (mean 11.1) years with stages 1 to 5 CKD. Thrombomodulin strongly correlated with creatinine (R=0.666; p<0.001), cystatin C (R=0.738; p<0.001), BNP (R=0.406; p=0.001), ADMA (R=0.353; p=0.01), oxLDL (R=0.340; p=0.009), 24-hour systolic (R=0.345; p=0.011) and mean (R=0.315; p<0.05) BP values, and left ventricular mass index (LVMI, R=0.293; p=0.024) and negatively with estimated glomerular filtration rate (R=−0.716; p<0.001). In children with CKD, TM strongly depended on kidney function parameters, oxLDL levels, and 24-hour systolic and mean BP values. Thrombomodulin seems to be a valuable marker of ED in CKD patients, correlating with CKD stage as well as oxidative stress, BP values, and LVMI.http://dx.doi.org/10.1155/2018/1619293
collection DOAJ
language English
format Article
sources DOAJ
author Dorota Drożdż
Monika Łątka
Tomasz Drożdż
Krystyna Sztefko
Przemko Kwinta
spellingShingle Dorota Drożdż
Monika Łątka
Tomasz Drożdż
Krystyna Sztefko
Przemko Kwinta
Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children
Oxidative Medicine and Cellular Longevity
author_facet Dorota Drożdż
Monika Łątka
Tomasz Drożdż
Krystyna Sztefko
Przemko Kwinta
author_sort Dorota Drożdż
title Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children
title_short Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children
title_full Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children
title_fullStr Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children
title_full_unstemmed Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children
title_sort thrombomodulin as a new marker of endothelial dysfunction in chronic kidney disease in children
publisher Hindawi Limited
series Oxidative Medicine and Cellular Longevity
issn 1942-0900
1942-0994
publishDate 2018-01-01
description Endothelial dysfunction (ED) and oxidative stress are potential new pathomechanisms of cardiovascular diseases in patients with chronic kidney disease (CKD). The aim of the study was to assess the association between endothelial dysfunction, oxidative stress biomarkers, and cardiovascular risk factors in children with CKD. Serum oxidized LDL (oxLDL), protein carbonyl group, urea, creatinine, cystatin C, thrombomodulin, asymmetric dimethylarginine (ADMA), von Willebrand factor, brain natriuretic peptide (BNP), lipids, high sensitivity C-reactive protein, intercellular adhesion molecule-1 levels, and albuminuria were measured. Anthropometric, ambulatory blood pressure (BP) measurements and echocardiography were performed. The studied group consisted of 59 patients aged 0.7–18.6 (mean 11.1) years with stages 1 to 5 CKD. Thrombomodulin strongly correlated with creatinine (R=0.666; p<0.001), cystatin C (R=0.738; p<0.001), BNP (R=0.406; p=0.001), ADMA (R=0.353; p=0.01), oxLDL (R=0.340; p=0.009), 24-hour systolic (R=0.345; p=0.011) and mean (R=0.315; p<0.05) BP values, and left ventricular mass index (LVMI, R=0.293; p=0.024) and negatively with estimated glomerular filtration rate (R=−0.716; p<0.001). In children with CKD, TM strongly depended on kidney function parameters, oxLDL levels, and 24-hour systolic and mean BP values. Thrombomodulin seems to be a valuable marker of ED in CKD patients, correlating with CKD stage as well as oxidative stress, BP values, and LVMI.
url http://dx.doi.org/10.1155/2018/1619293
work_keys_str_mv AT dorotadrozdz thrombomodulinasanewmarkerofendothelialdysfunctioninchronickidneydiseaseinchildren
AT monikałatka thrombomodulinasanewmarkerofendothelialdysfunctioninchronickidneydiseaseinchildren
AT tomaszdrozdz thrombomodulinasanewmarkerofendothelialdysfunctioninchronickidneydiseaseinchildren
AT krystynasztefko thrombomodulinasanewmarkerofendothelialdysfunctioninchronickidneydiseaseinchildren
AT przemkokwinta thrombomodulinasanewmarkerofendothelialdysfunctioninchronickidneydiseaseinchildren
_version_ 1725875028573028352